Ignite Creation Date:
2025-12-24 @ 3:49 PM
Ignite Modification Date:
2025-12-30 @ 3:39 AM
Study NCT ID:
NCT03490292
Status:
COMPLETED
Last Update Posted:
2024-07-26
First Post:
2018-02-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer
Sponsor:
University of Wisconsin, Madison
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-29
Start Date Type:
ACTUAL
Primary Completion Date:
2022-01-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-07-12
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-09
First Submit QC Date:
None
Study First Post Date:
2018-04-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-01-18
Results First Submit QC Date:
None
Results First Post Date:
2024-07-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-25
Last Update Post Date:
2024-07-26
Last Update Post Date Type:
ACTUAL